Health News Update: August 4, 2014

By ACSH Staff — Aug 04, 2014
Related content:
What I'm Reading (Aug. 17)
Are hepatitis C drugs too expensive?
The Cure for Ignorance About the Pharmaceutical Industry
Some rare common sense in our healthcare system? Treating hepatitis C, and getting it right
Doctor Shopping Makes A Comeback In Opioid Crisis
Catch the latest news on concerns regarding Gilead's $84,000 hepatitis C treatment drug Sovaldi, the declining sales of traditional cigarettes, and why prior authorization could be hurting the health care system

Catch the latest news on concerns regarding Gilead's $84,000 hepatitis C treatment drug Sovaldi, the declining sales of traditional cigarettes, and why prior authorization could be hurting the health care system

Tags:
Category
Harm Reduction

ACSH Staff

Recent articles by this author:
Fukushima's Tritiated Water
Investigation: Scientology-Linked Lawyers Spread Lies About Vaccines and GMOs, Attack Scientists
ACSH, Paul Thacker, and His 'Thacker of Trolls'
Why a Vaccine Can Provide Better Immunity than an Actual Infection
Perchlorate in Drinking Water
All articles by this author
ACSH relies on donors like you. If you enjoy our work, please contribute.

Make your tax-deductible gift today!

 

 

Popular articles

ACSH Podcasts

Latest from Henry

Latest from Josh

Latest from Chuck